Literature DB >> 16404555

Surgical treatment of hepatoblastoma in children.

Piotr Czauderna1, Jean-Bernard Otte, Derek J Roebuck, Dietrich von Schweinitz, Jack Plaschkes.   

Abstract

Hepatoblastoma is the most common liver malignancy in children. With rare exceptions, complete tumour resection is required to cure the patient. Radical tumour resection can be obtained either with standard partial hepatectomy or orthotopic liver transplantation. At present, the surgical approach to hepatoblastoma differs significantly between treatment groups in different parts of the world. Our aim was to review current surgical policy in hepatoblastoma. All aspects of surgery in hepatoblastoma are discussed, including biopsy, tumour resection principles, modern achievements in the field of liver surgery, and the indications and potential contraindications for liver transplantation. Every effort should be made to resect hepatoblastoma completely either by standard partial hepatectomy or by the use of liver transplantation in difficult or clearly unresectable cases.

Entities:  

Mesh:

Year:  2006        PMID: 16404555     DOI: 10.1007/s00247-005-0067-0

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  12 in total

1.  Chemotherapy for suspected hepatoblastoma without efforts at surgical resection is a bad practice.

Authors:  Milton J Finegold
Journal:  Med Pediatr Oncol       Date:  2002-11

2.  A new technique for resecting 'unresectable' liver tumors.

Authors:  R A Superina; D Bambini; R M Filler; P S Almond; G Geissler
Journal:  J Pediatr Surg       Date:  2000-09       Impact factor: 2.545

3.  Vascular occlusions for liver resections. Operative management and tolerance to hepatic ischemia: 142 cases.

Authors:  E Delva; Y Camus; B Nordlinger; L Hannoun; R Parc; H Deriaz; A Lienhart; C Huguet
Journal:  Ann Surg       Date:  1989-02       Impact factor: 12.969

4.  Living-related liver transplantation and vena cava reconstruction after total hepatectomy including the vena cava for hepatoblastoma.

Authors:  Christophe Chardot; Christine Saint Martin; André Gilles; Bénédicte Brichard; Magda Janssen; Etienne Sokal; Philippe Clapuyt; Jan Lerut; Raymond Reding; Jean-Bernard Otte
Journal:  Transplantation       Date:  2002-01-15       Impact factor: 4.939

5.  Extended hepatic resection with transplantation back-up for an "unresectable" tumour.

Authors:  A J Millar; P Hartley; D Khan; W Spearman; S Andronikou; H Rode
Journal:  Pediatr Surg Int       Date:  2001-07       Impact factor: 1.827

Review 6.  Childhood cancers: hepatoblastoma.

Authors:  C E Herzog; R J Andrassy; F Eftekhari
Journal:  Oncologist       Date:  2000

7.  Liver biopsy methods for pediatric oncology patients.

Authors:  F A Hoffer
Journal:  Pediatr Radiol       Date:  2000-07

8.  The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma--a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94.

Authors:  J Fuchs; J Rydzynski; H Hecker; H Mildenberger; D Bürger; D Harms; D V Schweinitz
Journal:  Eur J Pediatr Surg       Date:  2002-08       Impact factor: 2.191

9.  Liver resection using total vascular exclusion.

Authors:  P M Evans; D P Vogt; J T Mayes; J M Henderson; R M Walsh
Journal:  Surgery       Date:  1998-10       Impact factor: 3.982

Review 10.  Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience.

Authors:  J B Otte; J Pritchard; D C Aronson; J Brown; P Czauderna; R Maibach; G Perilongo; E Shafford; J Plaschkes
Journal:  Pediatr Blood Cancer       Date:  2004-01       Impact factor: 3.167

View more
  18 in total

Review 1.  Gastrointestinal intervention in children.

Authors:  Derek J Roebuck; Clare A McLaren
Journal:  Pediatr Radiol       Date:  2010-05-29

Review 2.  Neonatal tumours.

Authors:  Kokila Lakhoo; Helen Sowerbutts
Journal:  Pediatr Surg Int       Date:  2010-10-19       Impact factor: 1.827

3.  Hepatoblastoma in a Young Adult: a Rare Case Report and Review of the Literature.

Authors:  Jeewan Ram Vishnoi; Ajai Sasidhar; Sanjeev Misra; Puneet Pareek; Sudeep Khera; Sushil Kumar; Ankit Jain
Journal:  J Gastrointest Cancer       Date:  2020-03

4.  Metformin attenuates hypoxia-induced resistance to cisplatin in the HepG2 cell line.

Authors:  Hiromasa Fujita; Katsumi Hirose; Mariko Sato; Ichitaro Fujioka; Tamaki Fujita; Masahiko Aoki; Yoshihiro Takai
Journal:  Oncol Lett       Date:  2018-12-24       Impact factor: 2.967

5.  Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study.

Authors:  Wanbo Liu; Sheng Chen; Bing Liu
Journal:  Pediatr Surg Int       Date:  2016-09-06       Impact factor: 1.827

6.  Efficacy of preoperative transcatheter arterial chemoembolization combined with systemic chemotherapy for treatment of unresectable hepatoblastoma in children.

Authors:  Masakazu Hirakawa; Akihiro Nishie; Yoshiki Asayama; Nobuhiro Fujita; Kousei Ishigami; Tatsurou Tajiri; Tomoaki Taguchi; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2014-06-13       Impact factor: 2.374

Review 7.  Hepatoblastoma: an oncological review.

Authors:  Derek J Roebuck; Giorgio Perilongo
Journal:  Pediatr Radiol       Date:  2006-01-11

8.  ER stress and ASK1-JNK activation contribute to oridonin-induced apoptosis and growth inhibition in cultured human hepatoblastoma HuH-6 cells.

Authors:  Duo-te Cai; Hua Jin; Qi-Xing Xiong; Wei-Guang Liu; Zhi-gang Gao; Gui-xiong Gu; Yu-hui Qiu
Journal:  Mol Cell Biochem       Date:  2013-04-12       Impact factor: 3.396

Review 9.  Complete resection of hepatoblastoma originating in the caudate lobe: case report and literature review.

Authors:  Hiroyuki Koga; Yoichi Ishizaki; Junya Fujimura; Tadaharu Okazaki; Naho Fujiwara; Geoffrey J Lane; Toshiaki Shimizu; Atsuyuki Yamataka; Seiji Kawasaki
Journal:  Pediatr Surg Int       Date:  2009-11       Impact factor: 1.827

10.  Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.

Authors:  Rebecka L Meyers; Jon R Rowland; Mark Krailo; Zhengjia Chen; Howard M Katzenstein; Marcio H Malogolowkin
Journal:  Pediatr Blood Cancer       Date:  2009-12       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.